» Articles » PMID: 35330275

Routine Surveillance of Healthcare-Associated Infections Misses a Significant Proportion of Invasive Aspergillosis in Patients with Severe COVID-19

Overview
Journal J Fungi (Basel)
Date 2022 Mar 25
PMID 35330275
Authors
Affiliations
Soon will be listed here.
Abstract

Rates of invasive aspergillosis (IA) among COVID-19 ICU patients seem to reach over 30% in certain settings. At Vienna General Hospital (VGH), all rooms in COVID-19 ICUs were put under negative pressure as a protective measure, thus increasing the risk of exposure to environmental pathogens for patients. Even though all ICU patients are surveilled for healthcare-associated infections (HAI), there were concerns that the routine protocol might not be sufficient for IA detection. We reviewed the electronic patient charts of all patients with COVID-19 admitted to ICUs between 1 March 2020 and 31 July 2021 for fungal co- or superinfections, comparing four diagnostic algorithms based on different recommendations for the diagnosis of IA (according to EORTC/MSG, BM-AspICU, IAPA and CAPA) to our routine surveillance protocol. We found that out of 252 patients who were admitted to the ICU during the study period, 25 (9.9%) fulfilled the criteria of probable or possible IA of at least one algorithm. The IAPA definitions detected 25 and the CAPA definition 23 probable and 2 possible cases, out of which only 16 were classified as hospital-acquired IA by routine surveillance. In conclusion, adjustment of the routine protocol using a classification system especially designed for respiratory viral illness seems useful for the surveillance of IA in a highly vulnerable patient cohort.

Citing Articles

Indoor environment assessment of special wards of educational hospitals for the detection of fungal contamination sources: A multi-center study (2019-2021).

Ghazanfari M, Yazdani Charati J, Keikha N, Kholoujini M, Kermani F, Nasirzadeh Y Curr Med Mycol. 2023; 8(4):1-8.

PMID: 37736609 PMC: 10509496. DOI: 10.32598/CMM.2023.1370.


Identification of Histopathological Biomarkers in Fatal Cases of Coronavirus Disease: A Study on Lung Tissue.

Gheban-Rosca I, Gheban B, Pop B, Mironescu D, Siserman V, Jianu E Diagnostics (Basel). 2023; 13(12).

PMID: 37370934 PMC: 10297412. DOI: 10.3390/diagnostics13122039.


COVID-19 associated mold infections: Review of COVID-19 associated pulmonary aspergillosis and mucormycosis.

Huang S, Wu A, Shin-Jung Lee S, Huang Y, Lee C, Yang T J Microbiol Immunol Infect. 2022; 56(3):442-454.

PMID: 36586744 PMC: 9751001. DOI: 10.1016/j.jmii.2022.12.004.

References
1.
Verweij P, Bruggemann R, Azoulay E, Bassetti M, Blot S, Buil J . Taskforce report on the diagnosis and clinical management of COVID-19 associated pulmonary aspergillosis. Intensive Care Med. 2021; 47(8):819-834. PMC: 8220883. DOI: 10.1007/s00134-021-06449-4. View

2.
Garnacho-Montero J, Amaya-Villar R, Ortiz-Leyba C, Leon C, Alvarez-Lerma F, Nolla-Salas J . Isolation of Aspergillus spp. from the respiratory tract in critically ill patients: risk factors, clinical presentation and outcome. Crit Care. 2005; 9(3):R191-9. PMC: 1175876. DOI: 10.1186/cc3488. View

3.
Koehler P, Bassetti M, Chakrabarti A, Chen S, Colombo A, Hoenigl M . Defining and managing COVID-19-associated pulmonary aspergillosis: the 2020 ECMM/ISHAM consensus criteria for research and clinical guidance. Lancet Infect Dis. 2020; 21(6):e149-e162. PMC: 7833078. DOI: 10.1016/S1473-3099(20)30847-1. View

4.
Burghi G, Lemiale V, Seguin A, Lambert J, Lacroix C, Canet E . Outcomes of mechanically ventilated hematology patients with invasive pulmonary aspergillosis. Intensive Care Med. 2011; 37(10):1605-12. DOI: 10.1007/s00134-011-2344-8. View

5.
Meersseman W, Vandecasteele S, Wilmer A, Verbeken E, Peetermans W, Van Wijngaerden E . Invasive aspergillosis in critically ill patients without malignancy. Am J Respir Crit Care Med. 2004; 170(6):621-5. DOI: 10.1164/rccm.200401-093OC. View